Logo

CE

Celanese Corporation

CE

Celanese Corporation NYSE
$41.68 2.96% (+1.20)

Market Cap $4.56 B
52w High $75.84
52w Low $35.13
Dividend Yield 0.12%
P/E -1.48
Volume 951.19K
Outstanding Shares 109.50M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $2.419B $1.796B $-1.357B -56.098% $-12.39 $-982M
Q2-2025 $2.532B $302M $199M 7.859% $1.82 $505M
Q1-2025 $2.389B $308M $-21M -0.879% $-0.19 $358M
Q4-2024 $2.37B $1.944B $-1.914B -80.759% $-17.5 $-1.166B
Q3-2024 $2.648B $374M $116M 4.381% $1.06 $561M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $1.44B $22.169B $17.79B $3.954B
Q2-2025 $1.173B $23.713B $18.009B $5.276B
Q1-2025 $951M $23.197B $17.582B $5.186B
Q4-2024 $962M $22.857B $17.248B $5.175B
Q3-2024 $813M $25.892B $18.174B $7.274B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-1.358B $447M $-59M $-118M $267M $383M
Q2-2025 $202M $410M $-88M $-116M $222M $317M
Q1-2025 $-17M $37M $-98M $45M $-11M $-65M
Q4-2024 $-1.911B $494M $-128M $-189M $149M $389M
Q3-2024 $120M $79M $-100M $-376M $-372M $-9M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Acetyl Chain
Acetyl Chain
$1.14Bn $1.12Bn $1.11Bn $1.06Bn
Engineered Materials
Engineered Materials
$1.28Bn $1.29Bn $1.44Bn $1.38Bn

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown strongly over the last few years, helped by acquisitions and expansion, although it dipped slightly in the most recent year. The bigger concern is profitability: margins were healthy and fairly consistent until the latest year, when operating profit swung to a loss and overall results turned negative. That pattern suggests a mix of softer market conditions, cost pressure, and likely some one‑time items weighing on earnings. Historically, Celanese has shown it can earn solid profits, but the most recent year breaks that trend and introduces more uncertainty about near‑term earnings quality and stability.


Balance Sheet

Balance Sheet The balance sheet shows a company that has bulked up in size but taken on substantial debt to do it. Total assets have more than doubled compared with a few years ago, reflecting acquisitions and investment, while debt has risen even faster and remains high. Equity increased during the growth phase but has been pulled down by the recent loss, which tightens the cushion protecting lenders and shareholders. Cash on hand is modest relative to total obligations, so the company has less room to maneuver if conditions weaken. Overall, leverage is elevated and balance sheet risk is meaningfully higher than in the past.


Cash Flow

Cash Flow Despite the earnings swing, Celanese continues to generate positive cash from its core operations each year, which is an important strength. Operating cash flow and free cash flow were solid through the last several years, though they have eased off from prior peaks in the most recent period. Investment spending has been fairly steady and manageable relative to cash generation, suggesting discipline in capital projects. The picture is of a business that still throws off cash, but with less headroom than before to both service its heavier debt load and fund growth without trade‑offs.


Competitive Edge

Competitive Edge Celanese holds a strong position in key chemical value chains, especially through its integrated acetyl business, which gives it cost and supply advantages over many rivals. Its broad product range serves many end markets—from autos to medical to consumer goods—which helps spread risk when any one industry slows. The company’s proprietary processes, global manufacturing footprint, and close, technical relationships with customers add further resilience and create switching costs. That said, it still operates in a cyclical, capital‑intensive sector, so its competitive strengths cannot fully shield it from swings in industrial demand, raw‑material prices, or global economic slowdowns. High leverage also limits flexibility compared with some peers with cleaner balance sheets.


Innovation and R&D

Innovation and R&D Celanese is leaning hard into innovation, especially in higher‑value, specialized materials. It is developing advanced polymers for electric vehicles, electronics, and medical uses, where performance and reliability matter more than raw price. Its growing line of more sustainable products—using bio‑based, recycled, or carbon‑captured inputs—positions it well for tightening environmental expectations from regulators and large customers. The Chemille digital assistant is an example of using software and data to deepen customer ties and embed Celanese more firmly in design decisions. These initiatives, while not a guarantee of success, point toward a strategy of moving up the value chain and could gradually make earnings less volatile if they scale successfully.


Summary

Celanese today looks like a scaled‑up, more complex company with notable strengths but also elevated financial risk. On the positive side, it has strong positions in important chemical chains, a diversified customer base, and a clear push into higher‑margin, specialty and sustainable materials supported by meaningful innovation and digital tools. Cash generation has remained positive, which supports ongoing investment. On the risk side, the latest year’s loss breaks an otherwise solid profit record and raises questions about how quickly margins can recover. High debt, taken on during its growth and acquisition phase, now sits on top of a more cyclical earnings stream, increasing sensitivity to downturns and execution missteps. Going forward, the key issues to watch are margin recovery, debt reduction or refinancing progress, uptake of its sustainable and specialty product lines, and how well its innovation pipeline translates into steadier, higher‑quality earnings over time.